NEWCELLS BIOTECH

In News

Axol Bioscience acquires ophthalmology business from Newcells Biotech - News-Medical

News-Medical - Feb 18, 2026

Axol buys Newcells’ ophthalmology business to grow drug discovery portfolio - European Biotechnology Magazine

European Biotechnology Magazine - Feb 18, 2026

Jobs saved at Newcastle life sciences firm Newcells Biotech amid partial rescue deal - Business Live

Business Live - Feb 19, 2026

Axol Bioscience Ltd. Acquires Ophthalmology Business of Newcells Biotech - The Indian Practitioner

The Indian Practitioner - Feb 19, 2026

Newcells Biotech raises additional funding from investors - News-Medical

News-Medical - Dec 08, 2024

Newcells Biotech | Building in vitro models for drug discovery - mercia.co.uk

mercia.co.uk - Dec 13, 2023

In vitro modeling of small airway epithelium for studying barrier function and mucociliary clearance - News-Medical

News-Medical - May 13, 2025

Scalable human iPSC retinal organoids - News-Medical

News-Medical - May 13, 2025

Scalable human iPSC-derived retinal organoids for in vitro toxicology - News-Medical

News-Medical - May 13, 2025

High-content imaging assay for fibroblast activation and matrix deposition in pulmonary fibrosis - News-Medical

News-Medical - May 13, 2025

Advancing in vitro assays to model fibroblast-to-myofibroblast transition in fibrosis - News-Medical

News-Medical - May 13, 2025

Modeling EMT and FMT in lung fibrosis using high-content imaging for drug discovery - News-Medical

News-Medical - May 13, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment